{"nct_id":"NCT05005442","title":"A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2021-09-28","start_date_type":"ACTUAL","primary_completion_date":"2024-12-10","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}